The global Multiple Unit Pellet Systems market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Multiple Unit Pellet Systems is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Multiple Unit Pellet Systems is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Multiple Unit Pellet Systems include AstraZeneca, Merck KGaA, Janssen Pharmaceuticals, Inc. (Johnson & Johnson), Galderma, Novartis, GlaxoSmithKline, Perrigo Company, Cipla and Astellas Pharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Multiple Unit Pellet Systems, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Multiple Unit Pellet Systems.
Report Scope
The Multiple Unit Pellet Systems market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Multiple Unit Pellet Systems market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Multiple Unit Pellet Systems manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AstraZeneca
Merck KGaA
Janssen Pharmaceuticals, Inc. (Johnson & Johnson)
Galderma
Novartis
GlaxoSmithKline
Perrigo Company
Cipla
Astellas Pharma
Takeda Pharmaceutical Company
Eli Lilly and Company
Dr. Reddy's Laboratories
Endo International
Mylan Pharmaceuticals
Teva Pharmaceuticals
AbbVie (Allergan)
GlaxoSmithKline
Bayer
Segment by Type
Extended Release Dosage Form
Delayed Release Dosage Form
Delayed Release Orodispersible Dosage Form
Others
Segment by Application
Online Sales
Offline Sales
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Multiple Unit Pellet Systems manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Multiple Unit Pellet Systems in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Multiple Unit Pellet Systems Market Overview
1.1 Product Overview and Scope of Multiple Unit Pellet Systems
1.2 Multiple Unit Pellet Systems Segment by Type
1.2.1 Global Multiple Unit Pellet Systems Market Value Comparison by Type (2024-2030)
1.2.2 Extended Release Dosage Form
1.2.3 Delayed Release Dosage Form
1.2.4 Delayed Release Orodispersible Dosage Form
1.2.5 Others
1.3 Multiple Unit Pellet Systems Segment by Application
1.3.1 Global Multiple Unit Pellet Systems Market Value by Application: (2024-2030)
1.3.2 Online Sales
1.3.3 Offline Sales
1.4 Global Multiple Unit Pellet Systems Market Size Estimates and Forecasts
1.4.1 Global Multiple Unit Pellet Systems Revenue 2019-2030
1.4.2 Global Multiple Unit Pellet Systems Sales 2019-2030
1.4.3 Global Multiple Unit Pellet Systems Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Multiple Unit Pellet Systems Market Competition by Manufacturers
2.1 Global Multiple Unit Pellet Systems Sales Market Share by Manufacturers (2019-2024)
2.2 Global Multiple Unit Pellet Systems Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Multiple Unit Pellet Systems Average Price by Manufacturers (2019-2024)
2.4 Global Multiple Unit Pellet Systems Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Multiple Unit Pellet Systems, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Multiple Unit Pellet Systems, Product Type & Application
2.7 Multiple Unit Pellet Systems Market Competitive Situation and Trends
2.7.1 Multiple Unit Pellet Systems Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Multiple Unit Pellet Systems Players Market Share by Revenue
2.7.3 Global Multiple Unit Pellet Systems Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Multiple Unit Pellet Systems Retrospective Market Scenario by Region
3.1 Global Multiple Unit Pellet Systems Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Multiple Unit Pellet Systems Global Multiple Unit Pellet Systems Sales by Region: 2019-2030
3.2.1 Global Multiple Unit Pellet Systems Sales by Region: 2019-2024
3.2.2 Global Multiple Unit Pellet Systems Sales by Region: 2025-2030
3.3 Global Multiple Unit Pellet Systems Global Multiple Unit Pellet Systems Revenue by Region: 2019-2030
3.3.1 Global Multiple Unit Pellet Systems Revenue by Region: 2019-2024
3.3.2 Global Multiple Unit Pellet Systems Revenue by Region: 2025-2030
3.4 North America Multiple Unit Pellet Systems Market Facts & Figures by Country
3.4.1 North America Multiple Unit Pellet Systems Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Multiple Unit Pellet Systems Sales by Country (2019-2030)
3.4.3 North America Multiple Unit Pellet Systems Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Multiple Unit Pellet Systems Market Facts & Figures by Country
3.5.1 Europe Multiple Unit Pellet Systems Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Multiple Unit Pellet Systems Sales by Country (2019-2030)
3.5.3 Europe Multiple Unit Pellet Systems Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Multiple Unit Pellet Systems Market Facts & Figures by Country
3.6.1 Asia Pacific Multiple Unit Pellet Systems Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Multiple Unit Pellet Systems Sales by Country (2019-2030)
3.6.3 Asia Pacific Multiple Unit Pellet Systems Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Multiple Unit Pellet Systems Market Facts & Figures by Country
3.7.1 Latin America Multiple Unit Pellet Systems Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Multiple Unit Pellet Systems Sales by Country (2019-2030)
3.7.3 Latin America Multiple Unit Pellet Systems Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Multiple Unit Pellet Systems Market Facts & Figures by Country
3.8.1 Middle East and Africa Multiple Unit Pellet Systems Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Multiple Unit Pellet Systems Sales by Country (2019-2030)
3.8.3 Middle East and Africa Multiple Unit Pellet Systems Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Multiple Unit Pellet Systems Sales by Type (2019-2030)
4.1.1 Global Multiple Unit Pellet Systems Sales by Type (2019-2024)
4.1.2 Global Multiple Unit Pellet Systems Sales by Type (2025-2030)
4.1.3 Global Multiple Unit Pellet Systems Sales Market Share by Type (2019-2030)
4.2 Global Multiple Unit Pellet Systems Revenue by Type (2019-2030)
4.2.1 Global Multiple Unit Pellet Systems Revenue by Type (2019-2024)
4.2.2 Global Multiple Unit Pellet Systems Revenue by Type (2025-2030)
4.2.3 Global Multiple Unit Pellet Systems Revenue Market Share by Type (2019-2030)
4.3 Global Multiple Unit Pellet Systems Price by Type (2019-2030)
5 Segment by Application
5.1 Global Multiple Unit Pellet Systems Sales by Application (2019-2030)
5.1.1 Global Multiple Unit Pellet Systems Sales by Application (2019-2024)
5.1.2 Global Multiple Unit Pellet Systems Sales by Application (2025-2030)
5.1.3 Global Multiple Unit Pellet Systems Sales Market Share by Application (2019-2030)
5.2 Global Multiple Unit Pellet Systems Revenue by Application (2019-2030)
5.2.1 Global Multiple Unit Pellet Systems Revenue by Application (2019-2024)
5.2.2 Global Multiple Unit Pellet Systems Revenue by Application (2025-2030)
5.2.3 Global Multiple Unit Pellet Systems Revenue Market Share by Application (2019-2030)
5.3 Global Multiple Unit Pellet Systems Price by Application (2019-2030)
6 Key Companies Profiled
6.1 AstraZeneca
6.1.1 AstraZeneca Corporation Information
6.1.2 AstraZeneca Description and Business Overview
6.1.3 AstraZeneca Multiple Unit Pellet Systems Sales, Revenue and Gross Margin (2019-2024)
6.1.4 AstraZeneca Multiple Unit Pellet Systems Product Portfolio
6.1.5 AstraZeneca Recent Developments/Updates
6.2 Merck KGaA
6.2.1 Merck KGaA Corporation Information
6.2.2 Merck KGaA Description and Business Overview
6.2.3 Merck KGaA Multiple Unit Pellet Systems Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Merck KGaA Multiple Unit Pellet Systems Product Portfolio
6.2.5 Merck KGaA Recent Developments/Updates
6.3 Janssen Pharmaceuticals, Inc. (Johnson & Johnson)
6.3.1 Janssen Pharmaceuticals, Inc. (Johnson & Johnson) Corporation Information
6.3.2 Janssen Pharmaceuticals, Inc. (Johnson & Johnson) Description and Business Overview
6.3.3 Janssen Pharmaceuticals, Inc. (Johnson & Johnson) Multiple Unit Pellet Systems Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Janssen Pharmaceuticals, Inc. (Johnson & Johnson) Multiple Unit Pellet Systems Product Portfolio
6.3.5 Janssen Pharmaceuticals, Inc. (Johnson & Johnson) Recent Developments/Updates
6.4 Galderma
6.4.1 Galderma Corporation Information
6.4.2 Galderma Description and Business Overview
6.4.3 Galderma Multiple Unit Pellet Systems Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Galderma Multiple Unit Pellet Systems Product Portfolio
6.4.5 Galderma Recent Developments/Updates
6.5 Novartis
6.5.1 Novartis Corporation Information
6.5.2 Novartis Description and Business Overview
6.5.3 Novartis Multiple Unit Pellet Systems Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Novartis Multiple Unit Pellet Systems Product Portfolio
6.5.5 Novartis Recent Developments/Updates
6.6 GlaxoSmithKline
6.6.1 GlaxoSmithKline Corporation Information
6.6.2 GlaxoSmithKline Description and Business Overview
6.6.3 GlaxoSmithKline Multiple Unit Pellet Systems Sales, Revenue and Gross Margin (2019-2024)
6.6.4 GlaxoSmithKline Multiple Unit Pellet Systems Product Portfolio
6.6.5 GlaxoSmithKline Recent Developments/Updates
6.7 Perrigo Company
6.6.1 Perrigo Company Corporation Information
6.6.2 Perrigo Company Description and Business Overview
6.6.3 Perrigo Company Multiple Unit Pellet Systems Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Perrigo Company Multiple Unit Pellet Systems Product Portfolio
6.7.5 Perrigo Company Recent Developments/Updates
6.8 Cipla
6.8.1 Cipla Corporation Information
6.8.2 Cipla Description and Business Overview
6.8.3 Cipla Multiple Unit Pellet Systems Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Cipla Multiple Unit Pellet Systems Product Portfolio
6.8.5 Cipla Recent Developments/Updates
6.9 Astellas Pharma
6.9.1 Astellas Pharma Corporation Information
6.9.2 Astellas Pharma Description and Business Overview
6.9.3 Astellas Pharma Multiple Unit Pellet Systems Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Astellas Pharma Multiple Unit Pellet Systems Product Portfolio
6.9.5 Astellas Pharma Recent Developments/Updates
6.10 Takeda Pharmaceutical Company
6.10.1 Takeda Pharmaceutical Company Corporation Information
6.10.2 Takeda Pharmaceutical Company Description and Business Overview
6.10.3 Takeda Pharmaceutical Company Multiple Unit Pellet Systems Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Takeda Pharmaceutical Company Multiple Unit Pellet Systems Product Portfolio
6.10.5 Takeda Pharmaceutical Company Recent Developments/Updates
6.11 Eli Lilly and Company
6.11.1 Eli Lilly and Company Corporation Information
6.11.2 Eli Lilly and Company Multiple Unit Pellet Systems Description and Business Overview
6.11.3 Eli Lilly and Company Multiple Unit Pellet Systems Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Eli Lilly and Company Multiple Unit Pellet Systems Product Portfolio
6.11.5 Eli Lilly and Company Recent Developments/Updates
6.12 Dr. Reddy's Laboratories
6.12.1 Dr. Reddy's Laboratories Corporation Information
6.12.2 Dr. Reddy's Laboratories Multiple Unit Pellet Systems Description and Business Overview
6.12.3 Dr. Reddy's Laboratories Multiple Unit Pellet Systems Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Dr. Reddy's Laboratories Multiple Unit Pellet Systems Product Portfolio
6.12.5 Dr. Reddy's Laboratories Recent Developments/Updates
6.13 Endo International
6.13.1 Endo International Corporation Information
6.13.2 Endo International Multiple Unit Pellet Systems Description and Business Overview
6.13.3 Endo International Multiple Unit Pellet Systems Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Endo International Multiple Unit Pellet Systems Product Portfolio
6.13.5 Endo International Recent Developments/Updates
6.14 Mylan Pharmaceuticals
6.14.1 Mylan Pharmaceuticals Corporation Information
6.14.2 Mylan Pharmaceuticals Multiple Unit Pellet Systems Description and Business Overview
6.14.3 Mylan Pharmaceuticals Multiple Unit Pellet Systems Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Mylan Pharmaceuticals Multiple Unit Pellet Systems Product Portfolio
6.14.5 Mylan Pharmaceuticals Recent Developments/Updates
6.15 Teva Pharmaceuticals
6.15.1 Teva Pharmaceuticals Corporation Information
6.15.2 Teva Pharmaceuticals Multiple Unit Pellet Systems Description and Business Overview
6.15.3 Teva Pharmaceuticals Multiple Unit Pellet Systems Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Teva Pharmaceuticals Multiple Unit Pellet Systems Product Portfolio
6.15.5 Teva Pharmaceuticals Recent Developments/Updates
6.16 AbbVie (Allergan)
6.16.1 AbbVie (Allergan) Corporation Information
6.16.2 AbbVie (Allergan) Multiple Unit Pellet Systems Description and Business Overview
6.16.3 AbbVie (Allergan) Multiple Unit Pellet Systems Sales, Revenue and Gross Margin (2019-2024)
6.16.4 AbbVie (Allergan) Multiple Unit Pellet Systems Product Portfolio
6.16.5 AbbVie (Allergan) Recent Developments/Updates
6.17 GlaxoSmithKline
6.17.1 GlaxoSmithKline Corporation Information
6.17.2 GlaxoSmithKline Multiple Unit Pellet Systems Description and Business Overview
6.17.3 GlaxoSmithKline Multiple Unit Pellet Systems Sales, Revenue and Gross Margin (2019-2024)
6.17.4 GlaxoSmithKline Multiple Unit Pellet Systems Product Portfolio
6.17.5 GlaxoSmithKline Recent Developments/Updates
6.18 Bayer
6.18.1 Bayer Corporation Information
6.18.2 Bayer Multiple Unit Pellet Systems Description and Business Overview
6.18.3 Bayer Multiple Unit Pellet Systems Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Bayer Multiple Unit Pellet Systems Product Portfolio
6.18.5 Bayer Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Multiple Unit Pellet Systems Industry Chain Analysis
7.2 Multiple Unit Pellet Systems Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Multiple Unit Pellet Systems Production Mode & Process
7.4 Multiple Unit Pellet Systems Sales and Marketing
7.4.1 Multiple Unit Pellet Systems Sales Channels
7.4.2 Multiple Unit Pellet Systems Distributors
7.5 Multiple Unit Pellet Systems Customers
8 Multiple Unit Pellet Systems Market Dynamics
8.1 Multiple Unit Pellet Systems Industry Trends
8.2 Multiple Unit Pellet Systems Market Drivers
8.3 Multiple Unit Pellet Systems Market Challenges
8.4 Multiple Unit Pellet Systems Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
AstraZeneca
Merck KGaA
Janssen Pharmaceuticals, Inc. (Johnson & Johnson)
Galderma
Novartis
GlaxoSmithKline
Perrigo Company
Cipla
Astellas Pharma
Takeda Pharmaceutical Company
Eli Lilly and Company
Dr. Reddy's Laboratories
Endo International
Mylan Pharmaceuticals
Teva Pharmaceuticals
AbbVie (Allergan)
GlaxoSmithKline
Bayer
听
听
*If Applicable.